chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 29.0
Sex: F
Vaccine: FLU4, VARZOS
Symptoms: Chills, Fatigue, Headache, Menstruation delayed, Ovulation delayed
Clinical narrative: I received both the influenza and shingles vaccine around 11am on 15-Sep-2023. By 2pm, I started experiencing a headache, fatigue, fever (101 degrees F), and chills. I had aches all over my body.  My left arm was very sore.  My fever broke around 4am on 16-Sep-2023. I had a minor headache the rest of the day.   I had received these vaccinations on Menstrual Cycle Day 2. My cycles are typically 32 days long, with ovulation around Day 18. I track ovulation by taking my basal body temperature (BBT) at the same time every morning before getting out of bed, observing my cervical mucus, and using Ovulation Predictor Kits (OPK). I am on Cycle Day 55 and have not yet appeared to ovulate and have not had a menstrual period. I have taken multiple pregnancy tests (15-Oct-2023, 29-Oct-2023, 06-Nov-2023) and the results were negative. Note that I also received my COVID-19 booster on 06-Oct-2023 (Cycle Day 23); I will fill out another VAERS for the COVID-19 vaccine.
Age: 29.0
Sex: F
Vaccine: FLU4, VARZOS
Symptoms: Pain, Pain in extremity, Pregnancy test negative, Pyrexia
Clinical narrative: I received both the influenza and shingles vaccine around 11am on 15-Sep-2023. By 2pm, I started experiencing a headache, fatigue, fever (101 degrees F), and chills. I had aches all over my body.  My left arm was very sore.  My fever broke around 4am on 16-Sep-2023. I had a minor headache the rest of the day.   I had received these vaccinations on Menstrual Cycle Day 2. My cycles are typically 32 days long, with ovulation around Day 18. I track ovulation by taking my basal body temperature (BBT) at the same time every morning before getting out of bed, observing my cervical mucus, and using Ovulation Predictor Kits (OPK). I am on Cycle Day 55 and have not yet appeared to ovulate and have not had a menstrual period. I have taken multiple pregnancy tests (15-Oct-2023, 29-Oct-2023, 06-Nov-2023) and the results were negative. Note that I also received my COVID-19 booster on 06-Oct-2023 (Cycle Day 23); I will fill out another VAERS for the COVID-19 vaccine.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: Adult patient, 71 years of age, was incorrectly administered the Moderna Pediatric Covid 19 vaccination 6m-11 years.
Age: 55.0
Sex: M
Vaccine: COVID19, FLU4, VARZOS
Symptoms: Brain natriuretic peptide increased, Cardiac assistance device user, Cardiac imaging procedure abnormal, Cardiomyopathy, Catheterisation cardiac abnormal
Clinical narrative: Patient presented to the ED after experiencing shortness of breath on exertion.  Patient was found to have BNP of 3163 and chest x ray showed bilateral pleural effusions.  Echocardiography showed left ejection fraction of 10%.  Cardiac catheterization showed nonischemic cardiomyopathy and moderate pulmontary hypertension.  Patient was fitted for life vest and started on bumex, dapagliflozin, losartan and metoprolol. Patient underwent cardiac MRI which showed dilated cardiomyopathy.
Age: 55.0
Sex: M
Vaccine: COVID19, FLU4, VARZOS
Symptoms: Chest X-ray abnormal, Dilated cardiomyopathy, Dyspnoea exertional, Echocardiogram abnormal, Ejection fraction decreased
Clinical narrative: Patient presented to the ED after experiencing shortness of breath on exertion.  Patient was found to have BNP of 3163 and chest x ray showed bilateral pleural effusions.  Echocardiography showed left ejection fraction of 10%.  Cardiac catheterization showed nonischemic cardiomyopathy and moderate pulmontary hypertension.  Patient was fitted for life vest and started on bumex, dapagliflozin, losartan and metoprolol. Patient underwent cardiac MRI which showed dilated cardiomyopathy.
Age: 55.0
Sex: M
Vaccine: COVID19, FLU4, VARZOS
Symptoms: Pleural effusion, Pulmonary hypertension
Clinical narrative: Patient presented to the ED after experiencing shortness of breath on exertion.  Patient was found to have BNP of 3163 and chest x ray showed bilateral pleural effusions.  Echocardiography showed left ejection fraction of 10%.  Cardiac catheterization showed nonischemic cardiomyopathy and moderate pulmontary hypertension.  Patient was fitted for life vest and started on bumex, dapagliflozin, losartan and metoprolol. Patient underwent cardiac MRI which showed dilated cardiomyopathy.
Age: 11.0
Sex: F
Vaccine: HPV9, MNQ
Symptoms: Dizziness, Hypotension, Nausea
Clinical narrative: Patient began to feel nauseous and faint shortly after administration of vaccines. She laid supine on exam table for a few minutes and then felt well enough to go to school and leave office. Began to feel faint and nauseous again in waiting room while checking out at front desk. Returned to exam room and laid supine with feet elevated. Drank 5.5oz of apple juice, declined crackers, cool compress applied to forehead. Blood pressure and HR monitored, initially hypotensive and returned to normotensive after laying supine for approximately 30 minutes. Also had a popsicle before NP evaluated patient.
Age: 72.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19
Clinical narrative: hospitalized with COVID
Age: 11.0
Sex: F
Vaccine: COVID19, FLU4, TDAP
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Patient received 0.5mL dose of Moderna COVID 6m-11y formulation due to overfill of single-dose vial. Patient was discharged in stable condition with no adverse symptoms reported at time of vaccination.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Menstruation delayed, Pregnancy test negative
Clinical narrative: I had previously received the Influenza and Shingrx vaccines on 15-Sep-2023, which was on my Menstrual Cycle Day 2. My cycles are typically 32 days long, with ovulation around Day 18. I track ovulation by taking my basal body temperature (BBT) at the same time every morning before getting out of bed, observing my cervical mucus, and using Ovulation Predictor Kits (OPK).   I received this COVID-19 vaccine on Menstrual Cycle Day 23.  I am on Menstrual Cycle Day 55 and have not yet appeared to ovulate and have not had a menstrual period. I have taken multiple pregnancy tests (15-Oct-2023, 29-Oct-2023, 06-Nov-2023) and the results were negative.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac monitoring abnormal, Chest X-ray normal, Electrocardiogram normal, Fatigue, Feeling jittery
Clinical narrative: On the Friday after I got the vaccine I started having tachycardia when standing. I would feel very tired and jittery while standing. I went to the ER on 8/14/23 for high heart rate (180's) and high blood pressure.  I have never recovered and now have to take medication everyday.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Hypertension, Laboratory test normal, Tachycardia
Clinical narrative: On the Friday after I got the vaccine I started having tachycardia when standing. I would feel very tired and jittery while standing. I went to the ER on 8/14/23 for high heart rate (180's) and high blood pressure.  I have never recovered and now have to take medication everyday.
Age: 62.0
Sex: M
Vaccine: VARZOS
Symptoms: Atrial fibrillation, Body temperature increased, Condition aggravated, Heart rate increased, Lethargy
Clinical narrative: The vaccine sped up my heart rate significantly. Unfortunately this ?tripped? my heart and resulted in about 8 hours of Afib. I took my go to medicine, Fleccanide and after about 150 mgs of this, the Afib ceased. Also my temperature was raised to about 99 degrees and I felt lethargic. I feel much better now , 40 hours after the vaccine.
Age: 59.0
Sex: M
Vaccine: FLUC4
Symptoms: Extra dose administered
Clinical narrative: The patient had already received their flu shot for the season when they requested another one. The dose was administered prior to pharmacy verifying the order and catching the duplicate administration
Age: 54.0
Sex: F
Vaccine: FLUC4
Symptoms: Blood test normal, Cough, Injection site rash, Lip swelling, Pharyngeal swelling
Clinical narrative: First symptom was coughing that worsened quickly.  Used inhaler with no improvement. Then swelling of lips which progressed to full facial swelling and throat swelling. Drove to Hospital Emergency Dept. Treated with  benadryl, epi, steroids and ivfs. Monitored for 4 hours and discharged home.  Rash then  developed to vaccine administration site (left arm) 24 hours later.
Age: 54.0
Sex: F
Vaccine: FLUC4
Symptoms: Swelling face
Clinical narrative: First symptom was coughing that worsened quickly.  Used inhaler with no improvement. Then swelling of lips which progressed to full facial swelling and throat swelling. Drove to Hospital Emergency Dept. Treated with  benadryl, epi, steroids and ivfs. Monitored for 4 hours and discharged home.  Rash then  developed to vaccine administration site (left arm) 24 hours later.
Age: 77.0
Sex: F
Vaccine: COVID19, UNK, UNK
Symptoms: Cold sweat, Feeling hot, Loss of consciousness
Clinical narrative: Patient passed out while opening a high cupboard the morning after her vaccinations.  She felt warm and her husband found her cold/clammy.   Pt recovered and was seen by her prescriber the next day who recommended  reporting.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Peripheral swelling, Skin warm, Tenderness
Clinical narrative: the morning after IMZ, patient noticed a red, swollen area on arm, took some tylenol and put a cool compress on area. Area continued to be warm, swollen and tender to touch and went to Urgent Care on 11/5/2023
Age: 64.0
Sex: F
Vaccine: RSV
Symptoms: Respiratory tract congestion, Vertigo, Vertigo positional, Vestibular function test
Clinical narrative: "stuffy head" starting day after injection and continuing for 4 days. vertigo upon awakening on 5th day. Dix-hallpike and Epley physical therapy maneuvers on 6th day.  BPPV (right) confirmed by MD, low dose meclizine started 7th day and vestibular physical therapy continuous since.
Age: 54.0
Sex: M
Vaccine: FLU4
Symptoms: Abdominal pain, Blood test, Computerised tomogram, Diarrhoea, Electrocardiogram
Clinical narrative: Symptoms began with generalized fatigue around 5pm.  By 8pm pt was fatigued and went to bed.  States by 8:45pm he was experiencing "severe" abdominal cramps and had an episode of diarrhea.  While sitting on the toilet he experienced a syncopal episode, fell off the toilet, hitting his head on the shower curb and bathroom wall.  States sustained an avulsion above the left eyebrow and several abrasions to forehead and left parietal area.  States left eye is bruised and left eye is bloodshot.  EMS was called and FD responded along with county ambulance.  He was transported to clinic and treated by Dr.
Age: 54.0
Sex: M
Vaccine: FLU4
Symptoms: Eye contusion, Fall, Fatigue, Head injury, Ocular hyperaemia
Clinical narrative: Symptoms began with generalized fatigue around 5pm.  By 8pm pt was fatigued and went to bed.  States by 8:45pm he was experiencing "severe" abdominal cramps and had an episode of diarrhea.  While sitting on the toilet he experienced a syncopal episode, fell off the toilet, hitting his head on the shower curb and bathroom wall.  States sustained an avulsion above the left eyebrow and several abrasions to forehead and left parietal area.  States left eye is bruised and left eye is bloodshot.  EMS was called and FD responded along with county ambulance.  He was transported to clinic and treated by Dr.
Age: 54.0
Sex: M
Vaccine: FLU4
Symptoms: Skin abrasion, Syncope
Clinical narrative: Symptoms began with generalized fatigue around 5pm.  By 8pm pt was fatigued and went to bed.  States by 8:45pm he was experiencing "severe" abdominal cramps and had an episode of diarrhea.  While sitting on the toilet he experienced a syncopal episode, fell off the toilet, hitting his head on the shower curb and bathroom wall.  States sustained an avulsion above the left eyebrow and several abrasions to forehead and left parietal area.  States left eye is bruised and left eye is bloodshot.  EMS was called and FD responded along with county ambulance.  He was transported to clinic and treated by Dr.
Age: 35.0
Sex: M
Vaccine: FLU4
Symptoms: Periorbital swelling, Swelling face, Tenderness
Clinical narrative: After vaccine I experience periorbital tenderness and periorbital swelling throughout the day. This morning I woke up with left side facial swelling and periorbital swelling with no visual disturbance. Follow with occupational health who administer the vaccine and was told it was not the vaccine and to follow up with a variance report to see the following up step. No further test was done at occupational health and told to follow up with PCP if it got worse.
Age: 1.0
Sex: M
Vaccine: HEPA, IPV
Symptoms: Blood test, Breath holding, Chest X-ray, Electrocardiogram, Generalised tonic-clonic seizure
Clinical narrative: After injection into thights, child began to hold breath and then had gernalized tonic/clonic seizure.  Squad was called and transported to ER.  Kept overnight for observation.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Asthenia, COVID-19, COVID-19 pneumonia, Cough
Clinical narrative: BRIEF OVERVIEW: Admission Date: 7/25/2023 Discharge Date: Jul 28, 2023 Discharge Disposition:  home health care svc  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute respiratory failure with hypoxia COVID-19    HOSPITAL COURSE: Patient is a 82 y.o. male with past medical history significant for history of ESRD with renal transplant and now CKD stage 3, hypertension, paroxysmal AFib on Coumadin, Alzheimer's disease, depression, chronic diastolic CHF, type 2 diabetes, hypothyroidism who presented to the emergency department from home with complaints cough and generalized weakness.     Patient was found to be hypoxic and placed on 6 L nasal cannula to maintain oxygenation.  Patient was admitted to General Medicine for acute hypoxic respiratory failure.  Viral testing revealed COVID pneumonia.  Patient was initially started on Rocephin and azithromycin for concerns for community-acquired pneumonia, though quickly taken off this as COVID was determined to be the cause of his respiratory failure.   Given his history of renal transplant nephrology was consulted.  And assisted with care while he was hospitalized.   Patient was started on dexamethasone for COVID pneumonia.  He quickly improved and was able to decrease oxygen back to room air.  Patient was monitored at on room air without additional desaturations.  Given the improvement patient was discharged home in stable condition on 07/28.  Given that he was no longer on dexamethasone he was started on 5 mg of prednisone at the recommendation Nephrology given his history of renal transplant.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia, SARS-CoV-2 test positive
Clinical narrative: BRIEF OVERVIEW: Admission Date: 7/25/2023 Discharge Date: Jul 28, 2023 Discharge Disposition:  home health care svc  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute respiratory failure with hypoxia COVID-19    HOSPITAL COURSE: Patient is a 82 y.o. male with past medical history significant for history of ESRD with renal transplant and now CKD stage 3, hypertension, paroxysmal AFib on Coumadin, Alzheimer's disease, depression, chronic diastolic CHF, type 2 diabetes, hypothyroidism who presented to the emergency department from home with complaints cough and generalized weakness.     Patient was found to be hypoxic and placed on 6 L nasal cannula to maintain oxygenation.  Patient was admitted to General Medicine for acute hypoxic respiratory failure.  Viral testing revealed COVID pneumonia.  Patient was initially started on Rocephin and azithromycin for concerns for community-acquired pneumonia, though quickly taken off this as COVID was determined to be the cause of his respiratory failure.   Given his history of renal transplant nephrology was consulted.  And assisted with care while he was hospitalized.   Patient was started on dexamethasone for COVID pneumonia.  He quickly improved and was able to decrease oxygen back to room air.  Patient was monitored at on room air without additional desaturations.  Given the improvement patient was discharged home in stable condition on 07/28.  Given that he was no longer on dexamethasone he was started on 5 mg of prednisone at the recommendation Nephrology given his history of renal transplant.
Age: 45.0
Sex: M
Vaccine: UNK
Symptoms: Expired product administered
Clinical narrative: Vaccine error: Vaccine was administered after the use by date ( though not after the expiration date) Since it was being stored in the refrigerator.
Age: 73.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Asthenia, Chills, Fall, Fear, Mobility decreased
Clinical narrative: He got his vaccines, about 6 1/2 hours later he started getting chills, bad, really bad chills.  Then his arm started getting real sore.  He was that way for at least 3-4 hours with the chills.  He did not have enough to get into the shower to get a hot shower.  About 9:00 PM when he went to bed, took his medicine and he had to get up to go to the bathroom, slipped and fell on his side.  He had no strength in his right arm at all, like a miniture stroke.  He could not use his arm to get up, roll over or anything.  His wife could not get him up as he could not use his arm to get up.  She covered him up with a blanket until about 5:00 to 6:00 AM.  He then had enough strength to roll over and get up and get on the bed. The main thing was the no strength in his arm in the right arm.  It scared him bad, as they almost had to call 911 and he has never had any kind of reaction like this before.  He then had weakness for the following 2 days, and just resting and laying low.  On Friday he actually started feeling a little better, but that was his main AE was the lack of strength in the right arm.  He felt it was a stroke-like thing as he had no power to get up.  He did notify his doctor and they Emailed the advice nurse and said that if it persisted to come in.    He is now better and has strength back in his arm.  He has no long-term AE from it.  He will never get another COVID shot, and said that he would rather die first as it scared him so bad.  He is back to where he was before he got the vaccines.
Age: 73.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Muscular weakness, Pain in extremity
Clinical narrative: He got his vaccines, about 6 1/2 hours later he started getting chills, bad, really bad chills.  Then his arm started getting real sore.  He was that way for at least 3-4 hours with the chills.  He did not have enough to get into the shower to get a hot shower.  About 9:00 PM when he went to bed, took his medicine and he had to get up to go to the bathroom, slipped and fell on his side.  He had no strength in his right arm at all, like a miniture stroke.  He could not use his arm to get up, roll over or anything.  His wife could not get him up as he could not use his arm to get up.  She covered him up with a blanket until about 5:00 to 6:00 AM.  He then had enough strength to roll over and get up and get on the bed. The main thing was the no strength in his arm in the right arm.  It scared him bad, as they almost had to call 911 and he has never had any kind of reaction like this before.  He then had weakness for the following 2 days, and just resting and laying low.  On Friday he actually started feeling a little better, but that was his main AE was the lack of strength in the right arm.  He felt it was a stroke-like thing as he had no power to get up.  He did notify his doctor and they Emailed the advice nurse and said that if it persisted to come in.    He is now better and has strength back in his arm.  He has no long-term AE from it.  He will never get another COVID shot, and said that he would rather die first as it scared him so bad.  He is back to where he was before he got the vaccines.
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Anti-transglutaminase antibody, Blood immunoglobulin A, C-reactive protein increased, Candida infection
Clinical narrative: I'm unsure exactly when the symptoms started, but during her February 25, 2022 annual exam with her pediatrician we reported 2+ weeks of intermittent stomach pain.  We returned to the doctor on March 24, 2022 due to erythema nodosum.  In July 2022 she was officially diagnosed with Crohn's disease.  Note that she received MMR and TDAP during 2/25/22 exam.  Experienced swelling and rash as injection site.
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Colonoscopy abnormal, Crohn's disease, Endoscopy, Erythema nodosum, Faecal calprotectin
Clinical narrative: I'm unsure exactly when the symptoms started, but during her February 25, 2022 annual exam with her pediatrician we reported 2+ weeks of intermittent stomach pain.  We returned to the doctor on March 24, 2022 due to erythema nodosum.  In July 2022 she was officially diagnosed with Crohn's disease.  Note that she received MMR and TDAP during 2/25/22 exam.  Experienced swelling and rash as injection site.
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash, Injection site swelling, Laboratory test, Magnetic resonance imaging abdominal, Magnetic resonance imaging abdominal abnormal
Clinical narrative: I'm unsure exactly when the symptoms started, but during her February 25, 2022 annual exam with her pediatrician we reported 2+ weeks of intermittent stomach pain.  We returned to the doctor on March 24, 2022 due to erythema nodosum.  In July 2022 she was officially diagnosed with Crohn's disease.  Note that she received MMR and TDAP during 2/25/22 exam.  Experienced swelling and rash as injection site.
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Red blood cell sedimentation rate normal, Streptococcus test
Clinical narrative: I'm unsure exactly when the symptoms started, but during her February 25, 2022 annual exam with her pediatrician we reported 2+ weeks of intermittent stomach pain.  We returned to the doctor on March 24, 2022 due to erythema nodosum.  In July 2022 she was officially diagnosed with Crohn's disease.  Note that she received MMR and TDAP during 2/25/22 exam.  Experienced swelling and rash as injection site.
Age: 9.0
Sex: F
Vaccine: COVID19-2, FLU4, HPV9
Symptoms: Acute respiratory failure, Asthma, Asthmatic crisis, Blood pH decreased, COVID-19
Clinical narrative: Primary Care Physician at Discharge: MD  Admission Date: 11/2/2023 Discharge Date: 11/4/2023  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Severe persistent asthma with acute exacerbation [J45.51] Acute hypercapnic respiratory failure (HCC) [J96.02] Acute asthma exacerbation [J45.901]   HOSPITAL COURSE: 9 year old with known severe persistent asthma, severe obstructive sleep apnea, and obesity, who was admitted to the PICU severely ill with concern for impending death due to acute hypoxic respiratory failure secondary to status asthmaticus. Presented in extremis to the ED with a pH of 7.16, pCO2 76 and SpO2 of 66%, and was immediately placed on non-breather mask and continuous albuterol. She quickly needed escalation to BiPAP. She also received Atrovent, decadron, fluid bolus and magnesium sulfate. She was on the brink of intubation.    Upon arrival to the PICU, Atrovent and continuous albuterol were continued, as well as additional magnesium, IV and methylprednisolone and eventual aminophylline. Her film array revealed she was also COVID-19 positive, so ID was consulted and Remdesivir was given x3 daily doses. She experienced a rapid and remarkable recovery. She remained on iPAP 20, ePAP 7 until weaned off to HFNC the morning of 11/3/23. High flow weaned to room air by 1700 11/3/23. Continuous albuterol weaned to q2hr then q4hr by morning of discharge. Pulm was consulted 11/4/23 and went over recommended use of nightly BiPAP, and updated her asthma action plan to ensure green zone use of BID Symbicort. They suggested 7 day course of steroids, and to follow-up with them outpatient within a month with BiPAP download. Prednisone prescribed, and patient discharged 11/4/23.    BiPAP and Symbicort compliance are integral to her well-being, this was emphasized.
Age: 9.0
Sex: F
Vaccine: COVID19-2, FLU4, HPV9
Symptoms: Condition aggravated, Intensive care, Malaise, PCO2 decreased, Positive airway pressure therapy
Clinical narrative: Primary Care Physician at Discharge: MD  Admission Date: 11/2/2023 Discharge Date: 11/4/2023  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Severe persistent asthma with acute exacerbation [J45.51] Acute hypercapnic respiratory failure (HCC) [J96.02] Acute asthma exacerbation [J45.901]   HOSPITAL COURSE: 9 year old with known severe persistent asthma, severe obstructive sleep apnea, and obesity, who was admitted to the PICU severely ill with concern for impending death due to acute hypoxic respiratory failure secondary to status asthmaticus. Presented in extremis to the ED with a pH of 7.16, pCO2 76 and SpO2 of 66%, and was immediately placed on non-breather mask and continuous albuterol. She quickly needed escalation to BiPAP. She also received Atrovent, decadron, fluid bolus and magnesium sulfate. She was on the brink of intubation.    Upon arrival to the PICU, Atrovent and continuous albuterol were continued, as well as additional magnesium, IV and methylprednisolone and eventual aminophylline. Her film array revealed she was also COVID-19 positive, so ID was consulted and Remdesivir was given x3 daily doses. She experienced a rapid and remarkable recovery. She remained on iPAP 20, ePAP 7 until weaned off to HFNC the morning of 11/3/23. High flow weaned to room air by 1700 11/3/23. Continuous albuterol weaned to q2hr then q4hr by morning of discharge. Pulm was consulted 11/4/23 and went over recommended use of nightly BiPAP, and updated her asthma action plan to ensure green zone use of BID Symbicort. They suggested 7 day course of steroids, and to follow-up with them outpatient within a month with BiPAP download. Prednisone prescribed, and patient discharged 11/4/23.    BiPAP and Symbicort compliance are integral to her well-being, this was emphasized.
Age: 9.0
Sex: F
Vaccine: COVID19-2, FLU4, HPV9
Symptoms: Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: Primary Care Physician at Discharge: MD  Admission Date: 11/2/2023 Discharge Date: 11/4/2023  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Severe persistent asthma with acute exacerbation [J45.51] Acute hypercapnic respiratory failure (HCC) [J96.02] Acute asthma exacerbation [J45.901]   HOSPITAL COURSE: 9 year old with known severe persistent asthma, severe obstructive sleep apnea, and obesity, who was admitted to the PICU severely ill with concern for impending death due to acute hypoxic respiratory failure secondary to status asthmaticus. Presented in extremis to the ED with a pH of 7.16, pCO2 76 and SpO2 of 66%, and was immediately placed on non-breather mask and continuous albuterol. She quickly needed escalation to BiPAP. She also received Atrovent, decadron, fluid bolus and magnesium sulfate. She was on the brink of intubation.    Upon arrival to the PICU, Atrovent and continuous albuterol were continued, as well as additional magnesium, IV and methylprednisolone and eventual aminophylline. Her film array revealed she was also COVID-19 positive, so ID was consulted and Remdesivir was given x3 daily doses. She experienced a rapid and remarkable recovery. She remained on iPAP 20, ePAP 7 until weaned off to HFNC the morning of 11/3/23. High flow weaned to room air by 1700 11/3/23. Continuous albuterol weaned to q2hr then q4hr by morning of discharge. Pulm was consulted 11/4/23 and went over recommended use of nightly BiPAP, and updated her asthma action plan to ensure green zone use of BID Symbicort. They suggested 7 day course of steroids, and to follow-up with them outpatient within a month with BiPAP download. Prednisone prescribed, and patient discharged 11/4/23.    BiPAP and Symbicort compliance are integral to her well-being, this was emphasized.
Age: 1.0
Sex: F
Vaccine: HEPA, MMR, TDAP, VARCEL
Symptoms: Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: Gave Boostrix instead of Infanrix, no treatment given, observation by Dr., parent notified. Follow up call with parent as needed.
Age: 26.0
Sex: M
Vaccine: UNK
Symptoms: Product storage error, Vaccination error
Clinical narrative: Vaccine error: Vaccine was administered after the use by date ( though not after the expiration date) Since it was being stored in the refrigerator.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest pain, Coronary artery bypass, Cough, Culture urine positive
Clinical narrative: BRIEF OVERVIEW: Admission Date: 8/5/2023 Discharge Date: Aug 7, 2023 Discharge Disposition:  home or self care   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Shortness of breath [R06.02] Dyspnea [R06.00] Fever, unspecified fever cause [R50.9] Chest pain, unspecified type [R07.9]   HOSPITAL COURSE: 62-year-old with past medical history of chronic diastolic congestive heart failure, type 1 diabetes, diabetic neuropathy, history of coronary artery disease with CABG in 2023, hypertension, blindness, depression, chronic short-term memory loss, OSA not on CPAP, who presented with dyspnea and cough.  In ED febrile, mildly hypertensive, tachypneic to 30. ProBNP elevated to 7649 which is significantly elevated from her last few readings.  White blood cell count within normal limits.  COVID-19 positive.   Discharge from the ED discussed with the patient, however she was not comfortable with this and so decision made to admit under observation status.   On admission patient is placed on IV Lasix 40 mg 2 times a day.  Noted last discharge weight 93.1 kg.  Noted last echocardiogram 07/24/2023 ejection fraction 60% assessment for diastolic indeterminate.  By 8/6 standing weight was 92.7 kg.  Discussed with patient torsemide dose had been decreased from 60 mg daily to 20 mg 2 times a day.  Patient felt she did not have significant urine output from the lower dose.  On discharge patient will be given 40 mg once daily and advised to monitor daily weights and call physician if significant weight gain. Patient also noted positivity for COVID-19 on admission.  Patient received 1 day of remdesivir given risk for progression with underlying multiple medical comorbidities.  Patient was able to remain on room air including with ambulation.  Fevers improved.  Patient will be prescribed paxlovid at the reduced renal dosing on discharge.  Urinalysis and urine culture obtained in emergency department grew Klebsiella however patient has absolutely no dysuria or abdominal discomfort and fevers can be attributed to the COVID-19 infection.  Discussed with patient if she develops any urinary symptoms she will need to discuss with her PCP and start antibiotics however does not appear indicated at this time as patient asymptomatic.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Echocardiogram normal, Ejection fraction normal, Hypertension, Klebsiella test positive
Clinical narrative: BRIEF OVERVIEW: Admission Date: 8/5/2023 Discharge Date: Aug 7, 2023 Discharge Disposition:  home or self care   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Shortness of breath [R06.02] Dyspnea [R06.00] Fever, unspecified fever cause [R50.9] Chest pain, unspecified type [R07.9]   HOSPITAL COURSE: 62-year-old with past medical history of chronic diastolic congestive heart failure, type 1 diabetes, diabetic neuropathy, history of coronary artery disease with CABG in 2023, hypertension, blindness, depression, chronic short-term memory loss, OSA not on CPAP, who presented with dyspnea and cough.  In ED febrile, mildly hypertensive, tachypneic to 30. ProBNP elevated to 7649 which is significantly elevated from her last few readings.  White blood cell count within normal limits.  COVID-19 positive.   Discharge from the ED discussed with the patient, however she was not comfortable with this and so decision made to admit under observation status.   On admission patient is placed on IV Lasix 40 mg 2 times a day.  Noted last discharge weight 93.1 kg.  Noted last echocardiogram 07/24/2023 ejection fraction 60% assessment for diastolic indeterminate.  By 8/6 standing weight was 92.7 kg.  Discussed with patient torsemide dose had been decreased from 60 mg daily to 20 mg 2 times a day.  Patient felt she did not have significant urine output from the lower dose.  On discharge patient will be given 40 mg once daily and advised to monitor daily weights and call physician if significant weight gain. Patient also noted positivity for COVID-19 on admission.  Patient received 1 day of remdesivir given risk for progression with underlying multiple medical comorbidities.  Patient was able to remain on room air including with ambulation.  Fevers improved.  Patient will be prescribed paxlovid at the reduced renal dosing on discharge.  Urinalysis and urine culture obtained in emergency department grew Klebsiella however patient has absolutely no dysuria or abdominal discomfort and fevers can be attributed to the COVID-19 infection.  Discussed with patient if she develops any urinary symptoms she will need to discuss with her PCP and start antibiotics however does not appear indicated at this time as patient asymptomatic.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Prohormone brain natriuretic peptide increased, Pyrexia, SARS-CoV-2 test positive, Tachypnoea, Urine analysis abnormal
Clinical narrative: BRIEF OVERVIEW: Admission Date: 8/5/2023 Discharge Date: Aug 7, 2023 Discharge Disposition:  home or self care   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Shortness of breath [R06.02] Dyspnea [R06.00] Fever, unspecified fever cause [R50.9] Chest pain, unspecified type [R07.9]   HOSPITAL COURSE: 62-year-old with past medical history of chronic diastolic congestive heart failure, type 1 diabetes, diabetic neuropathy, history of coronary artery disease with CABG in 2023, hypertension, blindness, depression, chronic short-term memory loss, OSA not on CPAP, who presented with dyspnea and cough.  In ED febrile, mildly hypertensive, tachypneic to 30. ProBNP elevated to 7649 which is significantly elevated from her last few readings.  White blood cell count within normal limits.  COVID-19 positive.   Discharge from the ED discussed with the patient, however she was not comfortable with this and so decision made to admit under observation status.   On admission patient is placed on IV Lasix 40 mg 2 times a day.  Noted last discharge weight 93.1 kg.  Noted last echocardiogram 07/24/2023 ejection fraction 60% assessment for diastolic indeterminate.  By 8/6 standing weight was 92.7 kg.  Discussed with patient torsemide dose had been decreased from 60 mg daily to 20 mg 2 times a day.  Patient felt she did not have significant urine output from the lower dose.  On discharge patient will be given 40 mg once daily and advised to monitor daily weights and call physician if significant weight gain. Patient also noted positivity for COVID-19 on admission.  Patient received 1 day of remdesivir given risk for progression with underlying multiple medical comorbidities.  Patient was able to remain on room air including with ambulation.  Fevers improved.  Patient will be prescribed paxlovid at the reduced renal dosing on discharge.  Urinalysis and urine culture obtained in emergency department grew Klebsiella however patient has absolutely no dysuria or abdominal discomfort and fevers can be attributed to the COVID-19 infection.  Discussed with patient if she develops any urinary symptoms she will need to discuss with her PCP and start antibiotics however does not appear indicated at this time as patient asymptomatic.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: White blood cell count normal
Clinical narrative: BRIEF OVERVIEW: Admission Date: 8/5/2023 Discharge Date: Aug 7, 2023 Discharge Disposition:  home or self care   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Shortness of breath [R06.02] Dyspnea [R06.00] Fever, unspecified fever cause [R50.9] Chest pain, unspecified type [R07.9]   HOSPITAL COURSE: 62-year-old with past medical history of chronic diastolic congestive heart failure, type 1 diabetes, diabetic neuropathy, history of coronary artery disease with CABG in 2023, hypertension, blindness, depression, chronic short-term memory loss, OSA not on CPAP, who presented with dyspnea and cough.  In ED febrile, mildly hypertensive, tachypneic to 30. ProBNP elevated to 7649 which is significantly elevated from her last few readings.  White blood cell count within normal limits.  COVID-19 positive.   Discharge from the ED discussed with the patient, however she was not comfortable with this and so decision made to admit under observation status.   On admission patient is placed on IV Lasix 40 mg 2 times a day.  Noted last discharge weight 93.1 kg.  Noted last echocardiogram 07/24/2023 ejection fraction 60% assessment for diastolic indeterminate.  By 8/6 standing weight was 92.7 kg.  Discussed with patient torsemide dose had been decreased from 60 mg daily to 20 mg 2 times a day.  Patient felt she did not have significant urine output from the lower dose.  On discharge patient will be given 40 mg once daily and advised to monitor daily weights and call physician if significant weight gain. Patient also noted positivity for COVID-19 on admission.  Patient received 1 day of remdesivir given risk for progression with underlying multiple medical comorbidities.  Patient was able to remain on room air including with ambulation.  Fevers improved.  Patient will be prescribed paxlovid at the reduced renal dosing on discharge.  Urinalysis and urine culture obtained in emergency department grew Klebsiella however patient has absolutely no dysuria or abdominal discomfort and fevers can be attributed to the COVID-19 infection.  Discussed with patient if she develops any urinary symptoms she will need to discuss with her PCP and start antibiotics however does not appear indicated at this time as patient asymptomatic.
Age: 39.0
Sex: M
Vaccine: UNK
Symptoms: Product storage error, Vaccination error
Clinical narrative: Vaccine error: Vaccine was administered after the use by date ( though not after the expiration date) Since it was being stored in the refrigerator.
Age: 81.0
Sex: M
Vaccine: FLU4
Symptoms: Chest pain, Gastrointestinal pain, Hyperhidrosis, Pain in extremity, Pyrexia
Clinical narrative: approximately 42 hours after receiving the vaccination, the vaccinee developed fever, sweating, aching in arms, legs and chest, and intestinal pain. The intestinal pain was relieved by having a bowel movement, but other symptoms last between 1.5 to 2 weeks. Vaccinee has received "High Dose" flu vaccine in previous years and does not report as severe side effects.
Age: 89.0
Sex: M
Vaccine: COVID19-2, FLUA4
Symptoms: Arteriogram carotid abnormal, Asthenia, Blood sodium decreased, COVID-19, Cardiac telemetry
Clinical narrative: BRIEF OVERVIEW: Admission Date: 8/2/2023 Discharge Date: 8/4/2023 Discharge Disposition:  home health care svc      Active Issues Requiring Follow-up: Hyponatremia ?  No future appointments.   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Generalized weakness [R53.1] COVID-19 [U07.1]   HOSPITAL COURSE: Patient presented to the ED on 8/2/2023 with concerns for brief loss of consciousness, bilateral lower limb weakness, seizure like activity and possible facial droop on the left side. Blood pressure at presentation was 194/76. NIH 4.    We admitted for Loss of consciousness with possible left sided facial drop and seizure like activity: CT of the head showed no acute process. CTA showed high grade stenosis of the proximal right ICA and left common carotid and vertebral artery.  We consulted neurology they recommended aspirin 81mg, permissive hypertension,  MRI of the brain with and without contrast and continuous EEG. Both showed no acute process. We started patient on continuous telemetry and echo which shows LVEF of 62%. We also started patient on ASA + Plavix x 90 days, then ASA thereafter.   Patient also complained of Generalized weakness and multiple falls at home. We ordered MRI lumber spine to rule out stenosis. No high-grade spinal canal stenosis was seen but there was multiple Mild to moderate stenosis of the neural foramina. PT/OT /SLP were consulted. They saw patient and recommended patient be discharged into skilled nursing facility. Patient preferred to be home with family.   Patient has Hyponatremia on admission we discontinue the HCTZ medication he uses at home and we gave saline bolus and it improved. Blood sodium dropped the next day so we discharged patient home with sodium chloride salt and ordered a repeat lab in 2 days. We cc the PCP so that result could be followed-up. Patient examined today and discharged in stable condition. Follow-up instruction given to patient
Age: 89.0
Sex: M
Vaccine: COVID19-2, FLUA4
Symptoms: Carotid artery stenosis, Computerised tomogram head normal, Condition aggravated, Echocardiogram abnormal, Ejection fraction
Clinical narrative: BRIEF OVERVIEW: Admission Date: 8/2/2023 Discharge Date: 8/4/2023 Discharge Disposition:  home health care svc      Active Issues Requiring Follow-up: Hyponatremia ?  No future appointments.   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Generalized weakness [R53.1] COVID-19 [U07.1]   HOSPITAL COURSE: Patient presented to the ED on 8/2/2023 with concerns for brief loss of consciousness, bilateral lower limb weakness, seizure like activity and possible facial droop on the left side. Blood pressure at presentation was 194/76. NIH 4.    We admitted for Loss of consciousness with possible left sided facial drop and seizure like activity: CT of the head showed no acute process. CTA showed high grade stenosis of the proximal right ICA and left common carotid and vertebral artery.  We consulted neurology they recommended aspirin 81mg, permissive hypertension,  MRI of the brain with and without contrast and continuous EEG. Both showed no acute process. We started patient on continuous telemetry and echo which shows LVEF of 62%. We also started patient on ASA + Plavix x 90 days, then ASA thereafter.   Patient also complained of Generalized weakness and multiple falls at home. We ordered MRI lumber spine to rule out stenosis. No high-grade spinal canal stenosis was seen but there was multiple Mild to moderate stenosis of the neural foramina. PT/OT /SLP were consulted. They saw patient and recommended patient be discharged into skilled nursing facility. Patient preferred to be home with family.   Patient has Hyponatremia on admission we discontinue the HCTZ medication he uses at home and we gave saline bolus and it improved. Blood sodium dropped the next day so we discharged patient home with sodium chloride salt and ordered a repeat lab in 2 days. We cc the PCP so that result could be followed-up. Patient examined today and discharged in stable condition. Follow-up instruction given to patient
Age: 89.0
Sex: M
Vaccine: COVID19-2, FLUA4
Symptoms: Ejection fraction normal, Electroencephalogram normal, Fall, Hypertension, Hyponatraemia
Clinical narrative: BRIEF OVERVIEW: Admission Date: 8/2/2023 Discharge Date: 8/4/2023 Discharge Disposition:  home health care svc      Active Issues Requiring Follow-up: Hyponatremia ?  No future appointments.   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Generalized weakness [R53.1] COVID-19 [U07.1]   HOSPITAL COURSE: Patient presented to the ED on 8/2/2023 with concerns for brief loss of consciousness, bilateral lower limb weakness, seizure like activity and possible facial droop on the left side. Blood pressure at presentation was 194/76. NIH 4.    We admitted for Loss of consciousness with possible left sided facial drop and seizure like activity: CT of the head showed no acute process. CTA showed high grade stenosis of the proximal right ICA and left common carotid and vertebral artery.  We consulted neurology they recommended aspirin 81mg, permissive hypertension,  MRI of the brain with and without contrast and continuous EEG. Both showed no acute process. We started patient on continuous telemetry and echo which shows LVEF of 62%. We also started patient on ASA + Plavix x 90 days, then ASA thereafter.   Patient also complained of Generalized weakness and multiple falls at home. We ordered MRI lumber spine to rule out stenosis. No high-grade spinal canal stenosis was seen but there was multiple Mild to moderate stenosis of the neural foramina. PT/OT /SLP were consulted. They saw patient and recommended patient be discharged into skilled nursing facility. Patient preferred to be home with family.   Patient has Hyponatremia on admission we discontinue the HCTZ medication he uses at home and we gave saline bolus and it improved. Blood sodium dropped the next day so we discharged patient home with sodium chloride salt and ordered a repeat lab in 2 days. We cc the PCP so that result could be followed-up. Patient examined today and discharged in stable condition. Follow-up instruction given to patient
Age: 89.0
Sex: M
Vaccine: COVID19-2, FLUA4
Symptoms: Loss of consciousness, Magnetic resonance imaging head normal, Magnetic resonance imaging spinal abnormal, Muscular weakness, Scan with contrast normal
Clinical narrative: BRIEF OVERVIEW: Admission Date: 8/2/2023 Discharge Date: 8/4/2023 Discharge Disposition:  home health care svc      Active Issues Requiring Follow-up: Hyponatremia ?  No future appointments.   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Generalized weakness [R53.1] COVID-19 [U07.1]   HOSPITAL COURSE: Patient presented to the ED on 8/2/2023 with concerns for brief loss of consciousness, bilateral lower limb weakness, seizure like activity and possible facial droop on the left side. Blood pressure at presentation was 194/76. NIH 4.    We admitted for Loss of consciousness with possible left sided facial drop and seizure like activity: CT of the head showed no acute process. CTA showed high grade stenosis of the proximal right ICA and left common carotid and vertebral artery.  We consulted neurology they recommended aspirin 81mg, permissive hypertension,  MRI of the brain with and without contrast and continuous EEG. Both showed no acute process. We started patient on continuous telemetry and echo which shows LVEF of 62%. We also started patient on ASA + Plavix x 90 days, then ASA thereafter.   Patient also complained of Generalized weakness and multiple falls at home. We ordered MRI lumber spine to rule out stenosis. No high-grade spinal canal stenosis was seen but there was multiple Mild to moderate stenosis of the neural foramina. PT/OT /SLP were consulted. They saw patient and recommended patient be discharged into skilled nursing facility. Patient preferred to be home with family.   Patient has Hyponatremia on admission we discontinue the HCTZ medication he uses at home and we gave saline bolus and it improved. Blood sodium dropped the next day so we discharged patient home with sodium chloride salt and ordered a repeat lab in 2 days. We cc the PCP so that result could be followed-up. Patient examined today and discharged in stable condition. Follow-up instruction given to patient